Unknown OBSERVATIONAL NCT04780607

Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease

Multicenter Results of Mitral Valve Surgery in Patients With Rheumatic Heart Disease

Sponsor: Beijing Anzhen Hospital

Conditions Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease

Updated 4 times since 2021 Last updated: Mar 1, 2021 Started: Jan 1, 2011 Primary completion: Jan 1, 2024 Completion: Apr 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04780607, this observational or N/A phase trial focuses on Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease and remains ongoing. Sponsored by Beijing Anzhen Hospital, it has been updated 4 times since 2011, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
May 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Apr 2021 — May 2024 [monthly]

Recruiting

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Anzhen Hospital

Data source: Beijing Anzhen Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China